ACAD
Acadia Pharmaceuticals Inc.
Revenue to net incomeLast 12 months
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $1.2B | +19.4% |
| Gross profit | $1.1B | +17.9% |
| Operating income | $122M | — |
| Net income | $362M | — |
| EPS | $2.09 | — |
| Free cash flow | $82M | — |
Acadia Pharmaceuticals Inc.
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $1.2B | +19.4% |
| Gross profit | $1.1B | +17.9% |
| Operating income | $122M | — |
| Net income | $362M | — |
| EPS | $2.09 | — |
| Free cash flow | $82M | — |